We are a biopharmaceutical company utilizing our proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated.
$11.00 - $13.00
October 2, 2020
LADENBURG, THALMANN & CO., INC.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Immunome Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277